Infectious agents and cancer: criteria for a causal relation

Rickinson A, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, editors. Fields virology, 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001. p. 2575–627. Dalla-Favera, 1987, Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis, Ann. N.Y. Acad. Sci, 511, 207, 10.1111/j.1749-6632.1987.tb36249.x Raab-Traub N. Epstein-Barr virus and nasopharyngeal carcinoma. In: Goedert JJ, editor. Infectious causes of cancer: targets for intervention. Totowa, NJ: Humana; 2000. p. 93–111. Pathmanathan, 1995, Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia, Am. J. Pathol, 146, 1355 Glaser, 1997, Epstein-Barr virus-associated Hodgkin’s disease: epidemiologic characteristics in international data, Int. J. Cancer, 70, 375, 10.1002/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T de The’ G. Epidemiology of Epstein-Barr virus and associated diseases. In: Roizman B, editor. The herpesviruses, vol. I. New York: Plenum Press; 1982. p. 25–87. Henle, 1976, Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma, Int. J. Cancer, 17, 1, 10.1002/ijc.2910170102 Mueller, 1989, Hodgkin’s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis, N. Engl. J. Med, 320, 689, 10.1056/NEJM198903163201103 Raab-Traub, 1996, Pathogenesis of Epstein-Barr virus and its associated malignancies, Semin. Virol, 7, 315, 10.1006/smvy.1996.0039 Shackleford, 2004, Tumor viruses and cell-signaling pathways: deubiquitination versus ubiquitination, Mol Cell Biol, 24, 5089, 10.1128/MCB.24.12.5089-5093.2004 Raab-Traub, 1986, The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation, Cell, 47, 883, 10.1016/0092-8674(86)90803-2 Rooney, 1998, Treatment of relapsed Hodgkin’s disease using EBV-specific cytotoxic T cells, Ann. Oncol, 9, S129, 10.1023/A:1008496509406 Rooney, 1995, Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation, Lancet, 345, 9, 10.1016/S0140-6736(95)91150-2 Pope, 1995, Human lymphoid cell transformation by Epstein-Barr virus, Nat. New Biol, 246, 140, 10.1038/newbio246140a0 Hamilton-Dutoit, 1989, Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in situ hybridisation [letter], Lancet, 1, 552 Katz, 1989, Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases, J. Infect. Dis, 160, 589, 10.1093/infdis/160.4.589 Mosialos, 1995, The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family, Cell, 80, 389, 10.1016/0092-8674(95)90489-1 Miller, 1998, Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression, Mol. Cell. Biol, 18, 2835, 10.1128/MCB.18.5.2835 Wakisaka, 2003, Epstein-Barr virus induces invasion and metastasis factors, Anticancer Res, 23, 2133 Wakisaka, 2004, Epstein-Barr virus latent membrane protein-1 induces synthesis of hypoxia-inducible factor-lα, Mol Cell Biol, 24, 5223, 10.1128/MCB.24.12.5223-5234.2004 Zhang, 2002, Structure and function of interferon regulatory factor 7, Interferon and Cytokine Res, 22, 95, 10.1089/107999002753452700 Miller, 1994, An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking, Proc. Natl. Acad. Sci. U.S.A, 91, 772, 10.1073/pnas.91.2.772 Dykstra, 2001, Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR, Immunity, 14, 57, 10.1016/S1074-7613(01)00089-9 Scholle, 2000, Epstein Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt, J. Virol, 74, 10681, 10.1128/JVI.74.22.10681-10689.2000 Morrison, 2003, Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells, J. Virol, 22, 12276, 10.1128/JVI.77.22.12276-12284.2003 Shackelford, 2003, Epstein-Barr virus activates β-catenin in type III latently infected B-lymphocyte lines: association with deubiquitinating enzymes, Proc. Natl. Acad. Sci. U.S.A, 26, 1552 Huang, 1991, Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma, Cancer Genet. Cytogenet, 54, 91, 10.1016/0165-4608(91)90035-S Edwards, 2004, Potential selection of LMP1 variants in nasopharyngeal carcinoma, J. Virol, 78, 868, 10.1128/JVI.78.2.868-881.2004 Antman, 2000, Kaposi’s sarcoma, N. Engl. J. Med, 342, 1027, 10.1056/NEJM200004063421407 Nador, 1996, Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus, Blood, 88, 645, 10.1182/blood.V88.2.645.bloodjournal882645 Ablashi, 2002, Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases, Clin. Microbiol. Rev, 15, 439, 10.1128/CMR.15.3.439-464.2002 Boshoff, 2001, Epidemiology and pathogenesis of Kaposi’s sarcoma-associated herpesvirus, Philos. Trans. R. Soc. Lond. B Biol. Sci, 356, 517, 10.1098/rstb.2000.0778 Moore, 2003, Kaposi’s sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?, Annu. Rev. Microbiol, 57, 609, 10.1146/annurev.micro.57.030502.090824 Kliche, 1998, Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8, J. Virol, 72, 8143, 10.1128/JVI.72.10.8143-8149.1998 Flore, 1998, Transformation of primary human endothelial cells by Kaposi’s sarcoma-associated herpesvirus, Nature, 394, 588, 10.1038/29093 Damania, 2004, Modulation of cell signaling pathways by Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8), Cell Biochem. Biophys, 40, 1, 10.1385/CBB:40:3:305 Damania B. Gammaherpesviruses of non-human primates. The human herpesviruses: biology, therapy and immunoprophylaxis. Cambridge University; 2004; in press. Wang L, Wakisaka N, Tomlinson CC, DeWire S, Krall S, Pagano JS, et al. The Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 2004; 64. Cesarman, 2000, Viral G protein-coupled receptor and Kaposi’s sarcoma: a model of paracrine neoplasia?, J. Exp. Med, 191, 417, 10.1084/jem.191.3.417 Nicholas, 2003, Human herpesvirus-8-encoded signalling ligands and receptors, J Biomed Sci, 10, 475, 10.1007/BF02256109 Fehrmann, 2003, Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation, Oncogene, 22, 5201, 10.1038/sj.onc.1206554 Zur Hausen, 2002, Papillomaviruses and cancer: from basic studies to clinical. Application, Nature, 2, 342 White, 2004, Signaling pathways and polyomavirus oncoproteins: importance in malignant transformation, Gene Ther. Mol. Biol, 8, 19 Khalili, 2003, Human neurotropic polyomavirus, JCV, and its role in carcinogenesis, Oncogene, 22, 5181, 10.1038/sj.onc.1206559 Del Valle L, Gordon J, Ferrante P, Khalili K. JC virus in experimental and clinical brain tumorigenesis. In: Khalili K, Stoner GL, editors. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss Inc.; 2001. p. 409–30. Corallini A, Tognon M, Negrini M, Barbanti-Brodano G. Evidence for BK virus as a human tumor virus. In: Khalili K, Stoner GL, editors. Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss Inc., New York; 2001. p. 431–60. Arrington AS, Butel JS. SV40 and human tumors. In: Khalili K, Stoner GL, editors. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss Inc.; 2001. p. 461–89. Saenz-Robles, 2001, Transforming functions of simian virus 40, Oncogene, 20, 7899, 10.1038/sj.onc.1204936 Bocchetta, 2000, Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity, Proc. Natl. Acad. Sci. U.S.A, 97, 10214, 10.1073/pnas.170207097 Carbone, 2003, Different susceptibility of human mesothelial cells to polyomavirus infection and malignant transformation, Cancer Res, 63, 6125 Lednicky, 1995, Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors, Virology, 212, 710, 10.1006/viro.1995.1529 Waheed, 1999, Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells, Cancer Res, 59, 6068 Zur Hausen, 1999, Viruses in human cancers, Eur. J. Cancer, 35, 1878, 10.1016/S0959-8049(99)00291-9 Garcea, 2003, Simian virus 40 infection of humans, J. Virol, 77, 5039, 10.1128/JVI.77.9.5039-5045.2003 Beasley, 1981, Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan, Lancet, 2, 1129, 10.1016/S0140-6736(81)90585-7 Szmuness, 1978, Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association, Prog. Med. Virol, 24, 40 Sun, 2003, Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan, Am. J. Epidemiol, 157, 674, 10.1093/aje/kwg041 Buendia, 1992, Hepatitis B viruses and hepatocellular carcinoma, Adv. Cancer Res, 59, 167, 10.1016/S0065-230X(08)60306-1 Liang, 2000, Pathogenesis, natural history, treatment, and prevention of hepatitis C, Ann. Intern. Med, 132, 296, 10.7326/0003-4819-132-4-200002150-00008 Hollinger FB. Hepatitis B virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology, 3rd ed. Philadelphia: Lippincott-Raven; 1996. p. 2738–808. Brechot, 1998, Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action, J. Hepatol, 29, 173, 10.1016/S0168-8278(98)80001-9 El-Serag, 2002, Hepatocellular carcinoma and hepatitis C in the United State, Hepatology, 36, S74, 10.1002/hep.1840360710 Bréchot C. Hepatitis C virus: molecular biology and genetic variability. In: Schmid R, editor. Acute and chronic liver diseases. Basel, Switzerland: Kluwer Academic Publishers; 1996. p. 35–57. Nakamoto, 1998, Immune pathogenesis of hepatocellular carcinoma, J. Exp. Med, 188, 341, 10.1084/jem.188.2.341 Chisari, 1989, Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice, Cell, 59, 1145, 10.1016/0092-8674(89)90770-8 Kim, 1991, HBx gene of hepatitis B virus induces liver cancer in transgenic mice, Nature, 351, 317, 10.1038/351317a0 Bouchard, 2001, Calcium signaling by HBx protein in hepatitis B virus DNA replication, Science, 294, 2376, 10.1126/science.294.5550.2376 Moriya, 1998, The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice, Nat. Med, 4, 1065, 10.1038/2053 Lerat, 2002, Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus, Gastroenterology, 122, 352, 10.1053/gast.2002.31001 Matsubara, 1990, Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis, Mol. Biol. Med, 7, 243 Paterlini-Brechot, 2003, Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene, Oncogene, 22, 3911, 10.1038/sj.onc.1206492 Fourel, 1990, Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours, Nature, 347, 294, 10.1038/347294a0 Ming, 2002, Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China, Hepatology, 36, 1214, 10.1053/jhep.2002.36366 El-Serag, 2002, The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans, Am. J. Gastroenterol, 96, 2462, 10.1111/j.1572-0241.2001.04054.x Laurent-Puig, 2001, Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis, Gastroenterology, 120, 1763, 10.1053/gast.2001.24798 Blaser, 2004, Helicobacter pylor persistence: biology and disease, J. Clin. Investig, 113, 321, 10.1172/JCI20925 Falush, 2003, Traces of human migration in Helicobacter pylori populations, Science, 299, 1582, 10.1126/science.1080857 Peek, 2002, Helicobacter pylori and gastrointestinal tract adenocarcinomas, Nat. Rev. Cancer, 2, 28, 10.1038/nrc703 Helicobacter Cancer Collaborative Group (36 authors). Gastric cancer and Helicobacter pylori: a combined analysis of twelve case-control studies nested within prospective cohorts. Gut 2001;49:347–53. Tombola, 1999, Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolation, Biophys. J, 76, 1401, 10.1016/S0006-3495(99)77301-7 Blaser, 1995, Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk, Cancer Res, 55, 562 Figueiredo, 2002, Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma, J. Natl. Cancer Inst, 94, 1680, 10.1093/jnci/94.22.1680 Gallo, 2002, Human retroviruses after 20 years: a perspective from the past and prospects for their future control, Immunol. Rev, 185, 236, 10.1034/j.1600-065X.2002.18520.x Nonoyama, 1973, DNA of Epstein-Barr virus detected in tissue of Burkitt’s lymphoma and nasopharyngeal carcinoma, Proc. Natl. Acad. Sci. U.S.A, 70, 3265, 10.1073/pnas.70.11.3265 Pagano JS. The Epstein-Barr virus and malignancy: molecular evidence. In: Cold Spring Harbor symposium on quantitative biology: tumor viruses, vol. XXIX. New York: Cold Spring Harbor Laboratory, Cold Spring Harbor; 1975. p. 797–805. Pagano, 1973, Absence of Epstein-Barr viral DNA in American Burkitt’s lymphoma, N. Engl. J. Med, 289, 1395, 10.1056/NEJM197312272892604 Gravell, 1976, Epstein-Barr virus in an American patient with Burkitt’s lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line, J. Natl. Cancer Inst, 56, 7001, 10.1093/jnci/56.4.701 Wong, 2002, Commentary: new associations of human papillomavirus, simian virus 40, and Epstein-Barr virus with human cancer, J. Natl. Cancer Inst, 94, 1832, 10.1093/jnci/94.24.1832 Stratton K, et al. Immunization safety review SV40 contamination of polio vaccine and cancer. The National Academies Press; 2003. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855–9.